SMA carrier testing – validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion

[1]  T. Wienker,et al.  Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. , 1999, American journal of human genetics.

[2]  J. K. Day,et al.  Identification of a novel missense mutation of the SMNT gene in two siblings with spinal muscular atrophy , 1998, Neurogenetics.

[3]  T. Prior,et al.  Diagnosis of spinal muscular atrophy in an SMN non-deletion patient using a quantitative PCR screen and mutation analysis. , 1998, Journal of medical genetics.

[4]  B. Wirth,et al.  De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. , 1997, American journal of human genetics.

[5]  L. Surh,et al.  Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7 , 1997, Neurogenetics.

[6]  A. Burghes.  When is a deletion not a deletion? When it is converted. , 1997, American journal of human genetics.

[7]  K. Davies,et al.  Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. , 1997, American journal of human genetics.

[8]  J. Mendell,et al.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. , 1997, American journal of human genetics.

[9]  B. Wirth,et al.  Missense mutations in exon 6 of the survival motor neuron gene in patients with spinal muscular atrophy (SMA). , 1997, Human molecular genetics.

[10]  J. Nadeau,et al.  Cloning, characterization, and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene. , 1997, Genome research.

[11]  C. Ponting,et al.  Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism? , 1997, Human molecular genetics.

[12]  A. Munnich,et al.  The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease. , 1997, American journal of human genetics.

[13]  J. Melki,et al.  Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I. , 1996, Human molecular genetics.

[14]  B. Wirth,et al.  Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: new insights into molecular mechanisms responsible for the disease. , 1996, American journal of human genetics.

[15]  D. Parsons,et al.  An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene. , 1996, Human molecular genetics.

[16]  J. D. den Dunnen,et al.  Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5. , 1996, American journal of human genetics.

[17]  A. Munnich,et al.  Structure and organization of the human survival motor neurone (SMN) gene. , 1996, Genomics.

[18]  E. Velasco,et al.  Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. , 1996, Human molecular genetics.

[19]  A. Munnich,et al.  A frame–shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients , 1995, Nature Genetics.

[20]  H. Scheffer,et al.  Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. , 1995, American journal of human genetics.

[21]  B. Wirth,et al.  Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals. , 1995, Human molecular genetics.

[22]  J. Osinga,et al.  PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy , 1995, The Lancet.

[23]  K. Davies,et al.  Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. , 1995, Human molecular genetics.

[24]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[25]  D. Le Paslier,et al.  De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. , 1994, Science.

[26]  S. Antonarakis,et al.  Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): rapid detection of deletions and duplications of gene sequences. , 1994, Genomics.

[27]  X. Estivill,et al.  Uniparental inheritance of microsatellite alleles of the cystic fibrosis gene (CFTR): identification of a 50 kilobase deletion. , 1993, Human molecular genetics.

[28]  T. Munsat,et al.  International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany) , 1992, Neuromuscular Disorders.

[29]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[30]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[31]  J. Pearn.  CLASSIFICATION OF SPINAL MUSCULAR ATROPHIES , 1980, Lancet.

[32]  A. Emery.  The nosology of the spinal muscular atrophies. , 1971, Journal of medical genetics.